Calling Dr. Bauer – March 2019

Calling Dr. Bauer In all the exam rooms at our clinic, we have a large poster on the wall that displays the most recent inhalers available on the market. This is helpful for me to share this with each person so I can confirm exactly which inhalers he/she is using. It seems every six months…

Respiratory News – March 2019

Respiratory News The FDA has accepted a supplemen- tal New Drug Application for Xofluza (baloxavir marboxil) as a single-dose, oral treatment for people at high risk of complications from the flu, according to Genentech. A decision on approval of the new medication should come by November of this year. Studies found that Xofluza sig- nificantly…

The Ryan Report – March 2019

The Ryan Report Home Oxygen Guru – The HO2G Pen Ready for Spring! I don’t know about you, but I’m ready for spring and summer. Time to get out after being stuck inside for most of the winter. To those of you affected by spring flooding and weather-related disasters, I send positive vibes your way.…

Editor’s Note-March 2019

Editor’s Note Taking a break from the everyday routine of coping with lung disease proved to be a fun time on a recent Sea Puffer’s trip to the Caribbean. After touring Bonaire and seeing the salt flats, we had a White Party to celebrate finding the lost shaker of salt (aka, Phil Cassler of Wisconsin).…

The tax-filing season – January 2019

The tax-filing season The tax-filing season began on January 28, even amid the government shutdown. This is the first tax year under the Tax Cuts and Jobs Act – an over- haul of the code that doubled the standard deduction ($12,000 for singles and $24,000 for married-filing-jointly), and eliminated personal and dependent exemptions. The law…

Fibrosis File – January 2019

Fibrosis File Top Pulmonary Fibrosis stories of 2018 from Pulmonary Fibrosis News include:  CDTChe reported  that  dentists  and other dental healt hcare personnel may be at risk of developing idiopathic pulmonary fibrosis (IPF). Esbriet and Ofev show significant benefits in slowing IPF A 12-week treatment with experimental drug PBI-4050 stabilized lung function both as a…